PCINF0K Stock Latest News
Private CompaniesInfinity Bio Showcases Antibody Reactome Profiling Platform at IDWeek 20261w agoINF0K
Private CompaniesInfinity Bio Showcases Antibody Reactomics Platform at IDWeek 20261w agoINF0K
Private CompaniesInfinity Bio Highlights Assay Capabilities for Lyme Disease Antibody Profiling1w agoINF0K
Private CompaniesInfinity Bio Highlights Peptide-Level Antibody Mapping for Lyme Disease Research2w agoINF0K
Private CompaniesInfinity Bio Showcases Antibody Reactomics Platform Ahead of IDWeek 20262w agoINF0K
Private CompaniesInfinity Bio Highlights Antibody Profiling Capabilities for Infectious Disease Research2w agoINF0KPrivate CompaniesInfinity Bio Highlights Multi-Omics Opportunity in Viral Reactivation and Long COVID1M agoINF0K
Private CompaniesInfinity Bio Highlights Antibody Reactomics and MIPSA Platform at HUPO 20261M agoINF0K
Private CompaniesInfinity Bio Highlights Proteomics and Antibody Reactomics Focus at HUPO 20261M agoINF0K
Private CompaniesInfinity Bio Emphasizes Multi-Omic Approaches to APOE-Linked Alzheimer’s Risk5M agoINF0K
Private CompaniesInfinity Bio Positions Around Multi-Omic Cohort Analytics in Alzheimer’s Research5M agoINF0K
Private CompaniesInfinity Bio Highlights Antibody Reactome Profiling Opportunity in Sepsis Research5M agoINF0K
Private CompaniesInfinity Bio Targets Immunology Audience at FOCIS 2026 Conference5M agoINF0K
Private CompaniesInfinity Bio Highlights Clinical Immunology Focus Ahead of FOCIS 20265M agoINF0K
Private CompaniesSystems Immunology Cohort Spotlight Underscores Focus on Asian Precision Medicine5M agoINF0K
Private CompaniesMicrobiome Biomarkers Highlighted for Melanoma Immunotherapy Personalization5M agoINF0K
Private CompaniesInfinity Bio Highlights Microbiome Biomarkers for Melanoma Immunotherapy5M agoINF0K




